Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
neostigmine methylsulfate 2.5mg/1mL injection |
Is a |
False |
Neostigmine methylsulfate |
Inferred relationship |
Some |
|
neostigmine methylsulfate 2.5mg/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Neostigmine methylsulfate |
Inferred relationship |
Some |
|
Neostigmine methylsulfate [anesthesia] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Neostigmine methylsulfate |
Inferred relationship |
Some |
|
Neostigmine methylsulfate 0.5mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Neostigmine methylsulfate |
Inferred relationship |
Some |
|
Neostigmine methylsulfate 0.25mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Neostigmine methylsulfate |
Inferred relationship |
Some |
|
Neostigmine methylsulfate 1mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Neostigmine methylsulfate |
Inferred relationship |
Some |
|
Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Neostigmine methylsulfate |
Inferred relationship |
Some |
2 |
Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Neostigmine methylsulfate |
Inferred relationship |
Some |
2 |
Product containing precisely neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Neostigmine methylsulfate |
Inferred relationship |
Some |
1 |
Product containing precisely neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Neostigmine methylsulfate |
Inferred relationship |
Some |
1 |
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Neostigmine methylsulfate |
Inferred relationship |
Some |
1 |
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Neostigmine methylsulfate |
Inferred relationship |
Some |
1 |
Neostigmine methylsulfate 2.5 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Neostigmine methylsulfate |
Inferred relationship |
Some |
1 |
Neostigmine methylsulfate 2.5 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Neostigmine methylsulfate |
Inferred relationship |
Some |
1 |
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Neostigmine methylsulfate |
Inferred relationship |
Some |
2 |
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Neostigmine methylsulfate |
Inferred relationship |
Some |
2 |
Product containing precisely neostigmine methylsulfate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Neostigmine methylsulfate |
Inferred relationship |
Some |
1 |
Product containing precisely neostigmine methylsulfate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Neostigmine methylsulfate |
Inferred relationship |
Some |
1 |
Neostigmine methylsulfate 500 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Neostigmine methylsulfate |
Inferred relationship |
Some |
1 |
Neostigmine methylsulfate 500 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Neostigmine methylsulfate |
Inferred relationship |
Some |
1 |